Free Trial

Henry Schein (HSIC) Stock Price, News & Analysis

Henry Schein logo
$69.60 +1.39 (+2.04%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$69.61 +0.02 (+0.02%)
As of 08/22/2025 06:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Henry Schein Stock (NASDAQ:HSIC)

Key Stats

Today's Range
$68.66
$70.50
50-Day Range
$64.83
$74.67
52-Week Range
$60.56
$82.49
Volume
1.44 million shs
Average Volume
2.11 million shs
Market Capitalization
$8.44 billion
P/E Ratio
22.45
Dividend Yield
N/A
Price Target
$75.58
Consensus Rating
Hold

Company Overview

Henry Schein Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
72nd Percentile Overall Score

HSIC MarketRank™: 

Henry Schein scored higher than 72% of companies evaluated by MarketBeat, and ranked 170th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Henry Schein has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 4 buy ratings, 8 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Henry Schein has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Henry Schein's stock forecast and price target.
  • Earnings Growth

    Earnings for Henry Schein are expected to grow by 5.91% in the coming year, from $4.74 to $5.02 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Henry Schein is 22.45, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.40.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Henry Schein is 22.45, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 31.10.

  • Price to Earnings Growth Ratio

    Henry Schein has a PEG Ratio of 2.25. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Henry Schein has a P/B Ratio of 2.06. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Henry Schein's valuation and earnings.
  • Percentage of Shares Shorted

    7.45% of the float of Henry Schein has been sold short.
  • Short Interest Ratio / Days to Cover

    Henry Schein has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Henry Schein has recently increased by 8.66%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Henry Schein does not currently pay a dividend.

  • Dividend Growth

    Henry Schein does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.45% of the float of Henry Schein has been sold short.
  • Short Interest Ratio / Days to Cover

    Henry Schein has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Henry Schein has recently increased by 8.66%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Henry Schein has a news sentiment score of 1.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 25 news articles for Henry Schein this week, compared to 15 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Henry Schein insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.08% of the stock of Henry Schein is held by insiders.

  • Percentage Held by Institutions

    96.62% of the stock of Henry Schein is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Henry Schein's insider trading history.
Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

HSIC Stock News Headlines

This stock could leave NVDA in the dust
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.tc pixel
See More Headlines

HSIC Stock Analysis - Frequently Asked Questions

Henry Schein's stock was trading at $69.20 at the start of the year. Since then, HSIC stock has increased by 0.6% and is now trading at $69.60.

Henry Schein, Inc. (NASDAQ:HSIC) announced its quarterly earnings results on Tuesday, August, 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by $0.09. The business's quarterly revenue was up 3.3% compared to the same quarter last year.
Read the conference call transcript
.

Shares of Henry Schein split on Friday, September 15th 2017.The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were issued to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

The following companies are subsidiaries of Henry Schein: Prism Medical Products LLC, Elite Computer Italia, Southern Anesthesia & Surgical, Marrodent, Dental Cremer, RxWorks, Dental Trey, and others.

Henry Schein's top institutional investors include Artisan Partners Limited Partnership (5.33%), JPMorgan Chase & Co. (5.16%), State Street Corp (4.31%) and American Century Companies Inc. (3.76%). Insiders that own company stock include James P Breslawski, Stanley M Bergman, Michael S Ettinger, Lorelei Mcglynn, Mark E Mlotek, David B Brous Jr, Bradford C Connett, Philip A Laskawy and Kurt P Kuehn.
View institutional ownership trends
.

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Henry Schein investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR), AU Optronics (AUOTY) and The RMR Group (RMR).

Company Calendar

Last Earnings
8/05/2025
Today
8/23/2025
Next Earnings (Estimated)
11/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Health Care Distributors
Current Symbol
NASDAQ:HSIC
CIK
1000228
Employees
25,000
Year Founded
1932

Price Target and Rating

High Price Target
$84.00
Low Price Target
$70.00
Potential Upside/Downside
+8.6%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
$3.10
Trailing P/E Ratio
22.45
Forward P/E Ratio
14.68
P/E Growth
2.25
Net Income
$390 million
Net Margins
3.05%
Pretax Margin
4.07%
Return on Equity
14.36%
Return on Assets
5.52%

Debt

Debt-to-Equity Ratio
0.51
Current Ratio
1.41
Quick Ratio
0.78

Sales & Book Value

Annual Sales
$12.67 billion
Price / Sales
0.67
Cash Flow
$7.48 per share
Price / Cash Flow
9.30
Book Value
$33.71 per share
Price / Book
2.06

Miscellaneous

Outstanding Shares
121,270,000
Free Float
119,958,000
Market Cap
$8.44 billion
Optionable
Optionable
Beta
0.81

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:HSIC) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners